المؤلفون: Kim SI; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Szeto AH; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Morgan KP; Division of Practice Advancement and Experiential Education, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Department of Pharmacy, UNC Hospitals and Clinics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Brower B; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Dunn MW; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Khandani AH; Division of Molecular Imaging and Therapeutics, Department of Radiology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Godley PA; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Rose TL; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Basch EM; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Milowsky MI; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Whang YE; Division of Oncology, Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Crona DJ; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Pharmacy, UNC Hospitals and Clinics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

المصدر: PloS one [PLoS One] 2021 Jun 21; Vol. 16 (6), pp. e0253021. Date of Electronic Publication: 2021 Jun 21 (Print Publication: 2021).

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bone Neoplasms/*therapy , Chemoradiotherapy/*mortality , Prostatic Neoplasms, Castration-Resistant/*therapy , Radium/*therapeutic use, Abiraterone Acetate/administration & dosage ; Aged ; Aged, 80 and over ; Benzamides/administration & dosage ; Bone Neoplasms/secondary ; Follow-Up Studies ; Humans ; Male ; Nitriles/administration & dosage ; Phenylthiohydantoin/administration & dosage ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Survival Rate

المؤلفون: Nagaya N; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Nagata M; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Lu Y; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kanayama M; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Hou Q; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Hotta ZU; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Strategic Investigation on Comprehensive Cancer Network, Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies, the University of Tokyo, Tokyo, Japan., China T; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kitamura K; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Matsushita K; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Isotani S; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan., Muto S; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Advanced Informatics of Genetic Diseases, Juntendo University Graduate School of Medicine, Tokyo, Japan., Sakamoto Y; Department of Urology, Juntendo University Nerima Hospital, Tokyo, Japan., Horie S; Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

المصدر: PloS one [PLoS One] 2020 Jan 27; Vol. 15 (1), pp. e0226219. Date of Electronic Publication: 2020 Jan 27 (Print Publication: 2020).

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Surface/*blood , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Biomarkers, Tumor/*blood , Glutamate Carboxypeptidase II/*blood , Neoplastic Cells, Circulating/*pathology , Prostatic Neoplasms, Castration-Resistant/*pathology, Aged ; Aged, 80 and over ; Antigens, Surface/genetics ; Biomarkers, Tumor/genetics ; Cohort Studies ; Follow-Up Studies ; Glutamate Carboxypeptidase II/genetics ; Humans ; Male ; Middle Aged ; Neoplastic Cells, Circulating/metabolism ; Prognosis ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Survival Rate

المؤلفون: Schweizer MT; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Haugk K; Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Washington, United States of America., McKiernan JS; Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California, United States of America., Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA., Cheng HH; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Maes JL; Seattle Cancer Care Alliance, Seattle, Washington, United States of America., Dumpit RF; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Nelson PS; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Montgomery B; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., McCune JS; Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California, United States of America., Plymate SR; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Washington, United States of America., Yu EY; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

المصدر: PloS one [PLoS One] 2018 Jun 01; Vol. 13 (6), pp. e0198389. Date of Electronic Publication: 2018 Jun 01 (Print Publication: 2018).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Niclosamide/*administration & dosage , Phenylthiohydantoin/*analogs & derivatives , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics ; Benzamides ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm/drug effects ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Metastasis ; Niclosamide/adverse effects ; Niclosamide/pharmacokinetics ; Nitriles ; Phenylthiohydantoin/administration & dosage ; Phenylthiohydantoin/adverse effects ; Phenylthiohydantoin/pharmacokinetics ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology

المؤلفون: Pitcher B; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Khoja L; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Hamilton RJ; Department of Urologic Oncology, University Health Network, Toronto, Ontario, Canada., Abdallah K; Project Data Sphere LLC, Cary, North Carolina, United States of America., Pintilie M; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Joshua AM; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia.

المصدر: PloS one [PLoS One] 2017 Feb 02; Vol. 12 (2), pp. e0170544. Date of Electronic Publication: 2017 Feb 02 (Print Publication: 2017).

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/blood , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/mortality, Antineoplastic Agents/*adverse effects , Antineoplastic Agents/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostate-Specific Antigen/*blood , Taxoids/*adverse effects , Taxoids/*therapeutic use, Area Under Curve ; Cyclooxygenase 2 Inhibitors/adverse effects ; Cyclooxygenase 2 Inhibitors/therapeutic use ; Disease Progression ; Docetaxel ; Heparin, Low-Molecular-Weight/adverse effects ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Male ; Metformin/adverse effects ; Metformin/therapeutic use ; Models, Theoretical ; Proportional Hazards Models ; ROC Curve ; Treatment Outcome ; Warfarin/adverse effects ; Warfarin/therapeutic use

المؤلفون: Zhou T; Department of Urology, Changhai Hospital, The Second Military Medical University, 168 Changhai Road, Shanghai 200433, P.R. China., Zeng SX; Department of Urology, Changhai Hospital, The Second Military Medical University, 168 Changhai Road, Shanghai 200433, P.R. China., Ye DW; Department of Urology, Shanghai Cancer Center, Fudan University, Shanghai, P.R. China., Wei Q; Department of Urology, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, P.R. China., Zhang X; Department of Urology, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, P.R. China., Huang YR; Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China., Ye ZQ; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, P.R. China., Yang Y; Department of Urology, Beijing Cancer Hospital, Peking University, Beijing, P.R. China., Zhang W; Department of Urology, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, P.R. China., Tian Y; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China., Zhou FJ; Department of Urology, Cancer Hospital, Sun Yat-Sen University, Guangzhou, P.R. China., Jie J; Department of Urology, Peking University First Hospital, Beijing, P.R. China., Chen SP; Department of Urology, Fujian Union Hospital, Fuzhou, P.R. China., Sun Y; Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, P.R. China., Xie LP; Department of Urology, the First Affiliated Hospital, Zhejiang University, Hangzhou, P.R. China., Yao X; Department of Urology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, P.R. China., Na YQ; Department of Urology, Shougang Hospital, Peking University, Beijing, P.R. China., Sun YH; Department of Urology, Changhai Hospital, The Second Military Medical University, 168 Changhai Road, Shanghai 200433, P.R. China.

المصدر: PloS one [PLoS One] 2015 Jan 27; Vol. 10 (1), pp. e0117002. Date of Electronic Publication: 2015 Jan 27 (Print Publication: 2015).

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Adenocarcinoma/mortality ; Adenocarcinoma/secondary ; Adult ; Aged ; Aged, 80 and over ; China ; Disease-Free Survival ; Docetaxel ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Mitoxantrone/administration & dosage ; Prednisone/administration & dosage ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Quality of Life ; Taxoids/administration & dosage ; Treatment Outcome

المؤلفون: Fryzek JP; EpidStat Institute, Ann Arbor, Michigan, United States of America., Reichert H; EpidStat Institute, Ann Arbor, Michigan, United States of America., Summers N; Precision Health Economics, Los Angeles, California, United States of America., Townes L; EpidStat Institute, Ann Arbor, Michigan, United States of America., Deuson R; Medenomics, LLC, Moorpark, California, United States of America., Alexander DD; Precision Health Economics, Los Angeles, California, United States of America., Vanderpuye-Orgle J; Precision Health Economics, Los Angeles, California, United States of America.

المصدر: PloS one [PLoS One] 2018 Apr 11; Vol. 13 (4), pp. e0195790. Date of Electronic Publication: 2018 Apr 11 (Print Publication: 2018).

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Salvage Therapy*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Aged ; Androstenes/administration & dosage ; Benzamides ; Clinical Trials as Topic ; Docetaxel ; Humans ; Male ; Meta-Analysis as Topic ; Nitriles ; Phenylthiohydantoin/administration & dosage ; Phenylthiohydantoin/analogs & derivatives ; Prognosis ; Survival Rate ; Taxoids/administration & dosage

المؤلفون: Qi P; Institute of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China; Department of Clinical Laboratory, The Second Hospital of Lanzhou University, Lanzhou 730030, China., Chen M; Department of Urology, GanSu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China., Zhang LX; Institute of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China., Song RX; Institute of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China; Key Laboratory of Urological Diseases in Gansu Province, Lanzhou 730030, China., He ZH; Institute of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China; Department of Neurosurgery, The Second Hospital of Lanzhou University, Lanzhou 730030, China., Wang ZP; Institute of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China; Key Laboratory of Urological Diseases in Gansu Province, Lanzhou 730030, China.

المصدر: PloS one [PLoS One] 2015 Jul 20; Vol. 10 (7), pp. e0133803. Date of Electronic Publication: 2015 Jul 20 (Print Publication: 2015).

نوع المنشور: Comparative Study; Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Endothelin A Receptor Antagonists/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Atrasentan ; Disease-Free Survival ; Docetaxel ; Endothelin A Receptor Antagonists/administration & dosage ; Endothelin A Receptor Antagonists/adverse effects ; Humans ; Male ; Pyrrolidines/administration & dosage ; Pyrrolidines/adverse effects ; Pyrrolidines/therapeutic use ; Randomized Controlled Trials as Topic ; Taxoids/adverse effects ; Taxoids/therapeutic use ; Treatment Outcome

المؤلفون: Paul A. Godley, Ethan Basch, Andy H. Szeto, Amir H. Khandani, Matthew I. Milowsky, Blaine Brower, Mary W. Dunn, Daniel J. Crona, Stephanie I. Kim, Katherine P. Morgan, Tracy L. Rose, Young E. Whang

المصدر: PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0253021 (2021)

مصطلحات موضوعية: Oncology, Male, Abiraterone Acetate, Cancer Treatment, Metastasis, Prostate cancer, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Basic Cancer Research, Clinical endpoint, Medicine and Health Sciences, Aged, 80 and over, Multidisciplinary, Prostate Cancer, Hazard ratio, Prostate Diseases, Anemia, Chemoradiotherapy, Hematology, Prognosis, Survival Rate, Prostatic Neoplasms, Castration-Resistant, Research Design, Benzamides, Medicine, Anatomy, medicine.drug, Radium, Research Article, Radium-223, medicine.medical_specialty, Clinical Research Design, Science, Urology, Pain, Bone Neoplasms, Research and Analysis Methods, Exocrine Glands, Signs and Symptoms, Internal medicine, Nitriles, Phenylthiohydantoin, medicine, Enzalutamide, Humans, Adverse effect, Aged, Retrospective Studies, Proportional hazards model, business.industry, Correction, Cancers and Neoplasms, Biology and Life Sciences, medicine.disease, Log-rank test, Genitourinary Tract Tumors, chemistry, Prostate Gland, Adverse Events, Clinical Medicine, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c3165d5ecb27b223bf5875f8cfda8e1
http://europepmc.org/articles/PMC8216516

المؤلفون: Shuji Isotani, Shigeo Horie, Masayoshi Nagata, Naoya Nagaya, Zen-u Hotta, Kosuke Kitamura, Mayuko Kanayama, Satoru Muto, Kazuhito Matsushita, Toshiyuki China, Qi Hou, Yan Lu, Yoshiro Sakamoto

المصدر: PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0226219 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Glutamate Carboxypeptidase II, Male, medicine.medical_treatment, Cancer Treatment, Gene Expression, Artificial Gene Amplification and Extension, urologic and male genital diseases, Polymerase Chain Reaction, Biochemistry, Cohort Studies, Prostate cancer, 0302 clinical medicine, Circulating tumor cell, Antineoplastic Combined Chemotherapy Protocols, Glutamate carboxypeptidase II, Medicine and Health Sciences, Aged, 80 and over, Multidisciplinary, Pharmaceutics, Prostate Cancer, Prostate Diseases, Middle Aged, Neoplastic Cells, Circulating, Prognosis, Survival Rate, Prostatic Neoplasms, Castration-Resistant, 030220 oncology & carcinogenesis, Cohort, Antigens, Surface, Androgens, Medicine, Research Article, medicine.medical_specialty, Science, Urology, Research and Analysis Methods, 03 medical and health sciences, Antigen, Drug Therapy, Diagnostic Medicine, Internal medicine, medicine, Genetics, Cancer Detection and Diagnosis, Biomarkers, Tumor, Chemotherapy, Humans, Clinical significance, Molecular Biology Techniques, Survival rate, Molecular Biology, Aged, business.industry, Cancers and Neoplasms, Biology and Life Sciences, medicine.disease, Hormones, Genitourinary Tract Tumors, 030104 developmental biology, Specimen Preparation and Treatment, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19ea9b46c70f5e788f369a87ea707f3
http://europepmc.org/articles/PMC6984691

المؤلفون: Nicholas Summers, Robert Deuson, Lindsay Townes, Jackie Vanderpuye-Orgle, Heidi Reichert, Jon P. Fryzek, Dominik D. Alexander

المصدر: PLoS ONE
PLoS ONE, Vol 13, Iss 4, p e0195790 (2018)

مصطلحات موضوعية: Oncology, Male, Cancer Treatment, lcsh:Medicine, Docetaxel, Pathology and Laboratory Medicine, Prostate cancer, chemistry.chemical_compound, White Blood Cells, 0302 clinical medicine, Animal Cells, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, 030212 general & internal medicine, lcsh:Science, Clinical Trials as Topic, Multidisciplinary, Prostate Cancer, Hazard ratio, Prostate Diseases, Anemia, Hematology, Prognosis, Survival Rate, Prostatic Neoplasms, Castration-Resistant, Cabazitaxel, Research Design, 030220 oncology & carcinogenesis, Comparators, Benzamides, Engineering and Technology, Androstenes, Taxoids, Cellular Types, medicine.drug, Research Article, Diarrhea, medicine.medical_specialty, Neutropenia, Clinical Research Design, Urology, Immune Cells, Immunology, Pain, Gastroenterology and Hepatology, Research and Analysis Methods, 03 medical and health sciences, Signs and Symptoms, Meta-Analysis as Topic, Diagnostic Medicine, Internal medicine, Nitriles, Phenylthiohydantoin, medicine, Enzalutamide, Humans, Adverse effect, Aged, Salvage Therapy, Blood Cells, business.industry, lcsh:R, Cancers and Neoplasms, Biology and Life Sciences, Cell Biology, medicine.disease, Abdominal Pain, Clinical trial, Regimen, Genitourinary Tract Tumors, chemistry, lcsh:Q, Adverse Events, Electronics, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a8c297b2500827e4fdffce97b9a0ff
http://europepmc.org/articles/PMC5895064